Sterling Biotech cuts conversion price on 0% convertibles due 2012

By Marisa Wong

Milwaukee, June 7 - Sterling Biotech Ltd. gave notice that the conversion price of its $250 million zero-coupon convertible bonds due 2012 was reset on May 15.

The conversion price was adjusted to Rs. 163.13 from Rs. 204.576 per share.

Sterling Biotech is a manufacturer of pharmaceutical gelatin based in Mumbai.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.